Theme: Integrating the Milestones in Gynecologic Oncology Globally

Gynecologic Oncology 2016

Renowned Speakers

Gynecologic Oncology 2016

OMICS International invites all the participants across the globe to attend the " Experts Meeting on Gynecologic Oncology”slated on May 19-21, 2016 at San Antonio, USA.

Theme: Integrating the Milestones in Gynecologic Oncology Globally

Global Gynecology Oncology conferences provides three days of robust discussions on methods and strategies related to management and quality improvement of Cancer therapy as well as explore new ideas and concepts on a global scale and topics include ovarian cancer,Breast cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer.

Nearly 80,000 women are diagnosed with Oncology Gynecology in the United States, and half of those are uterine cancer diagnoses with a mortality of 8,000 women per year. Ovarian cancer found to be the 2nd most common Oncology Gynecology with about 22,000 new cases per year, leading to 16,000 deaths yearly. Mortality for cervical cancer have decreased as Pap smears have become commonplace. Still, there are about 12,000 diagnoses every year with about 4,200 women die from this disease annually. Vulvar and vaginal cancer are relatively rare and when caught and treated early offers of reasonably good prognosis. 4,500 women are diagnosed with vulvar cancer each year, with about 950 women die from it. Vaginal cancer, meanwhile, account for about 2,600 diagnoses per year, and about 840 deaths. Every woman is at risk for developing a Oncology Gynecology. It is estimated that there will be about 98,000 new cases diagnosed and approximately 30,000 deaths from Oncology Gynecology in the United States during 2015 as per American Cancer Society. Out of which Uterine cancer has the large portion about 50% of cases with an estimated mortality rate of 18.5%. The Ovarian cancer has the highest estimated mortality rate at 66%.

OMICS International along with itssubsidiary ConferenceSeries Ltd  which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical(Cancer meeting, cancer conferences, oncology society, European oncology conferences, surgical oncology,global cancer conference, cancer conferences, American oncology society), Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

Why to attend ?

With members from around the world focused on learning about Oncology Gynecology; this is your best opportunity to reach the largest assemblage of participants from the Gynecologists community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Oncology Gynecology are hallmarks of this conference.

Target Audience

  • Oncologists

  • Radiologists

  • Scientists

  • Surgeons

  • Pathologists

  • Researchers

  • Faculty

  • Students

  • Allied Health Professionals

  • Oncology Gynecology Associations and Societies

  • Business Entrepreneurs

  • Software Developing Companies

  • Medical Devices Companies

  • Biomedical Companies

  • Biotechnology Companies

  • Data Management Companies

OMICS International cancer conferences invites all the participants from all over the world to attend ‘Experts Meeting on Gynecologic Oncology’ during May 19-21,2016 at San Antonio, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Global Gynecology Oncology 2016 is a platform to discuss and learn about Cause of the cancer its Symptoms, Pathogenesis, Types, Tests, Screening, Diagnosis and Monitoring Gynecology Treatment, Surgical Methods, Prevention, clinical trials and research, Sexual and reproductive issues and Role of imaging in Gynecology Oncology conferences.

Track 1: Gynecologic Oncology

Oncology Gynecology is the study about any cancer that begins in a woman's reproductive organs. The five Gynecology cancers starts in the woman's pelvis at different places. Each cancer is unique by its symptoms, signs, risk factors and in their strategies of prevention. All these five different types of Gynecology Cancers risk increases with the age. When these cancers were diagnosed at their early stages, the treatment will be more efficient.The five major types of cancer affect a woman's reproductive organs are ovarian, uterine, cervical,vulvar, and vaginal cancerAll these as a group are known as Gynecology cancers 

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA.5th World Congress on Cancer Therapy, September 28-30, 2015, Alanta,USA.10th Global Annual Oncologists Meeting,July 11-13, 2016 Cologne, Germany. International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil. International Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Alanta,USA..Cancer Diagnostics Conference & Expo, June 13-15,2016 Rome,Italy. 11th Asia-Pacific Oncologists Annual Meeting, July 11-13, 2016 Kuala Lumpur, Malaysia.International Conference on Cervical Cancer, September 22-23, 2016 Vienna, Austria. International Conference and Expo on Molecular & Cancer Biomarkers, November 28-30, 2016 Baltimore, USA. Global Summit on Melanoma and Carcinoma,July 14-15, 2016, Brisbane, Australia.Advances in Ovarian Cancer Research: Exploiting Vulnerabilities, October 17 - 20, 2015, Florida, USA. Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, March 6—10, 2016, Canada, General Assembly and International Conference of Asian Pacific Organisation for Cancer Prevention (APOCP), 13 - 16 April 2016, Brisbane, Australia. 6th International Symposium on Hereditary Breast and Ovarian Cancer, 10–13 May 2016, Montréal, Canada., 16th Biennial Meeting of the International Gynecologic Cancer Society, October 29 – 31, Lisbon.3rd World Congress on Ovulation Induction & Ovarian Stimulation Protocols, Fetal and Women's Imaging.The 22nd World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI).Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, Keystone Symposia: Cancer Immunotherapy Immunity and Immunosuppression Meet Targeted Therapies.Cancer and Autoimmunity 2016 — Emerging Target Therapies in Cancer & Autoimmunity.The International Federation of Gynecology and Obstetrics (FIGO).

Track 2: Gynecologic Oncology: Cause

There are many factors that cause Gynecology cancer. Medical research has discovered that some classes of genes, called Oncogenes and tumor suppressor genes promote the growth of cancer. The abnormal function of these genes can be acquired (e.g., through smoking, aging, Environmental influences) or inherited. Almost all cervical cancers and some Cancer of the vagina and vulva are caused by a virus known as HPV (Human Papilloma virus).

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

 Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA.International Conference on Cervical Cancer, September 22-23, 2016 Vienna, Austria. International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil. 7th Global Summit on Cancer Therapy, October 05-07, 2015, Dubai,UAE. Cancer Diagnostics Conference & Expo, June 13-15,2016 Rome, Italy. 8th Euro Global Summit on Cancer Therapy , November 03-05, 2015, Valencia,Spain. 2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. 2nd International Conference on Antimicrobial Agents and Chemotherapy, June 06-07,2016 Dallas, USA.International Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Alanta,USA. 9th Indo Global Summit on Cancer Therapy, November 02-04, 2015, Hyderabad,India.International Conference on Leukemia and Bone marrow Transplantation, November 10-12,2016,Istanbul,Turkey.ASCO/BGICS Joint Session at the Breast Gynecological International Cancer Conference, January 14- 15, 2016, Egypt.ASCO/RUSSCO Joint Session at the Russian Gynecological Cancer Conference, March 18- 19, 2016, Russia, , Tenth AACR-JCA Joint Conference on Breakthroughs in Cancer Research: From Biology to Therapeutics, February 16 - 20, 2016 Hawaii, USA. The International Federation of Gynecology and Obstetrics (FIGO), 4-9 October 2015, Vancouver, Canada.International Symposium on Advanced Ovarian Cancer: Optimal Therapy, 06 Mar 2016, Valencia, Spain.International Symposium on Advanced Ovarian Cancer: Optimal Therapy 2015, Polycystic Ovarian Syndrome Conference.Women's Health Western Caribbean Cruise - December 2015,27– 3 January 2016,Fort Lauderdale, United States.Selected Topics in Nephrology, Primary Care and Women's Health Eastern Caribbean Cruise,23–30 January 2016,Fort Lauderdale, United States.Family Medicine: Women's Health Eastern Caribbean Cruise,28 – 6 March 2016,Fort Lauderdale, United States.2nd EMEL Symposium on Endometriosis and Chronic Pelvic Pain,4–5 March 2016,Dubai, United Arab Emirates.23rd World Congress on Controversies in Obstetrics, Gynecology and Infertility,21–23 March 2016,Melbourne, Australia.

Track 3: Gynecologic Oncology: Symptoms

Oncology Gynecology can’t be detected normally and risk increases with age, so it’s important to go for regular health checkups from which it can be recognised. Gynecology cancer  Symptoms are not same for every individual and every Gynecology cancer, like In some cases Vaginal bleeding which is unusual and it might be vaginal, cervical cancers and uterine cancer. In other cases symptoms like Pelvic pressure which might be Ovarian, Uterine and VulvarBloating and Abdominal back pain which might be a symptom of ovarian cancer. Itching/burning of the Vulva will be present in Vulvar cancer.

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

International Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Alanta,USA. 4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai, UAE. 2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. 2nd International Conference on Antimicrobial Agents and Chemotherapy, June 06-07,2016 Dallas, USA. Cancer Diagnostics Conference & Expo, June 13-15,2016 Rome, Italy.International Conference on Leukemia and Bone marrow Transplantation, November 10-12,2016,Istanbul,Turkey.International Conference on Oral, Mouth and Throat, August 18-20, 2016, Portland, USA.International Conference on Mesothelioma, November 03-04, 2016, Valencia, spain. International Conference on Leukemia and Bone marrow Transplantation, November 10-12,2016,Istanbul,Turkey.International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil.12th Focus on Gynecologic Cancers Conference, October 9, 2015, Philadelphia, PA. SGO Annual Meeting on Women’s Cancer, March 19-22, 2016, San Diego, CA.NCRI Cancer Conference,01-04 November,2015,UK. IARC 50th Anniversary Conference, 7–10 June 2016, Lyon, France, NRG Oncology january 2016 Meeting resources, January 21-24, 2016 in Atlanta, GA.19th SIS World Congress on Breast Healthcare,5–8 May 2016,Warsaw, Poland.INSUOG 2016,6–8 May 2016,HYDERABAD, India.6th International Symposium on Hereditary Breast and Ovarian Cancer,10–13 May 2016,Montréal, Canada.Primary Care and Women's Health: Key Topics and Core Strategies Eastern Caribbean Cruise,5–12 June 2016,Fort Lauderdale, United States.Women's Health Western Mediterranean Cruise,31 July – 7 August 2016,Barcelona, Spain.

Track 4: Gynecologic Oncology: Diagnosis

Out of all Gynecology cancer only cervical cancer has a screening test—the Pap test—that can find this cancer early. When treatment works best it helps in prevention of cervical cancer for finding pre-cancers. HPV Test Human Papilloma vaccine looks for  infection which can be used along with the Pap test for screening women aged 30 years and older. It also provides more information when Pap test results are unclear for women aged 21 and olderRobotic surgery and miniature instruments were used to enhance a gynecologic oncologist’s  laparoscopic skills when removing a patient’s uterus and cervix.

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA.10th Global Annual Oncologists Meeting,July 11-13, 2016 Cologne, Germany.International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil. International Conference on Cervical Cancer,September22to23,2016Vienna,Austria. International Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Alanta,USA.4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai,7th Global Summit on Cancer Therapy, October 05-07, 2015, Dubai,UAE.Markers in Cancer Diagnostic Development Tutorial,  December 1-2, 2015 Brussels, Belgium. Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, March 6—10, 2016, Canada. 2nd Annual Oncology Asia, Sep 14- 17 2015, Tokyo, Japan.Cancer-2016 International Cancer Study & Therapy Conference, April 4-6, 2016   Baltimore,USA. 8th General Assembly and International Conference of Asian Pacific Organization for Cancer Prevention (APOCP8),April 13-16,2016,Australia.Pregnancy and Childbirth 2016,13–15 September 2016,London, United Kingdom.16th Biennial Meeting of the International Gynecologic Cancer Society,29–31 October 2016,Lisbon, Portugal.Cancer Vaccines: Targeting Cancer Genes for Immunotherapy,6–10 March 2016,Whistler, Canada.Changing Prospects for Cancer 'A good survival',11 March 2016,Manchester, United Kingdom.General Assembly and International Conference of Asian Pacific Organisation for Cancer Prevention (APOCP),13–16 April 2016,Brisbane, Australia.

Track 5: Gynecologic Oncology: Treatment

Gynecology cancers are treated by using one or more of the following ways such as surgery that is by removal of cancer tissue, Radiation Therapy alone or combined with chemotherapy that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from further dividing. . The choice of treatment therapies depends on the type & stage of the cancer. In generally a gynecology cancer patient often treated with combined therapies for efficient results. 

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA.International Conference on Oral, Mouth and Throat, August 18-20, 2016, Portland, USA. International Conference on Mesothelioma, November 03-04, 2016, Valencia, spain. .5th World Congress on Cancer Therapy, September 28-30, 2015, Alanta,USA.4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai, UAE. 2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. 2nd International Conference on Antimicrobial Agents and Chemotherapy, June 06-07,2016 Dallas, USA. Cancer Diagnostics Conference & Expo, June 13-15,2016 Rome,Italy. 11th Asia-Pacific Oncologists Annual Meeting, July 11-13, 2016 Kuala Lumpur, Malaysia.European Cancer Congress,Sep 25-29,2016,Austria.ESMO Symposium on Signalling Pathways in Cancer 2016, Mar 04-05,2016, Spain.IMPAKT 2016 Breast Cancer Conference, May 12-14,2016, Brussels, Belgium, 11th Meet the Professor. Advanced International Breast Cancer Course (AIBCC).25th Annual Congress of the Romanian Society for Radiotherapy and Medical Oncology (RSRMO), 15-17 October, 2015, Sibiu,Romania. Innovation and Biomarkers in Cancer Drug Development (IBCD), December 3-4,2015, Brussels, Belgium.Global Cancer: Occurrence, Causes, and Avenues To Prevention,7–10 June 2016,Lyon, France44th American Association for Gynecological Laparoscopy (AAGL) Global Congress on Minimally Invasive Gynecology,15-19 November 2015, Las Vegas, Nevada, USA.Early Pregnancy and Acute Gynaecology,27-28 November 2015,  London, UK2016 Progress and Controversies in Gynecologic Oncology ,22-23 January 2016, Barcelona, Spain19th Senologic International Society (SIS) World Congress on Breast Healthcare,5-8 May 2016, Warsaw, Poland.10th Athens Congress on Women's Health and Disease (website active soon),1-3 September 2016, Athens, Greece.

Track 6: Breast Cancer

Breast cancer is the most common invasive Oncology Gynecology in females worldwide. It accounts for 16% of all female cancers and 22.9% of invasive cancers in women. 18.2% of all cancer deaths worldwide, including both males and females, are from breast cancer. Breast cancer rates are much higher in developed nations compared to developing ones. There are several reasons for this, with possibly life-expectancy being one of the key factors - breast cancer is more common in elderly women; women in the richest countries live much longer than those in the poorest nations. The different lifestyles and eating habits of females in rich and poor countries are also contributory factors, experts believe.

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

5th World Congress on Cancer Therapy, September 28-30, 2015, Alanta,USA.10th Global Annual Oncologists Meeting,July 11-13, 2016 Cologne, Germany. International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil. International Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Alanta,USA.4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai, UAE.Cancer Diagnostics Conference & Expo, June 13-15,2016 Rome,Italy. 11th Asia-Pacific Oncologists Annual Meeting, July 11-13, 2016 Kuala Lumpur, Malaysia.International Conference on Cervical Cancer, September 22-23, 2016 Vienna, Austria. International Conference and Expo on Molecular & Cancer Biomarkers, November 28-30, 2016 Baltimore, USA. Global Summit on Melanoma and Carcinoma,July 14-15, 2016, Brisbane, Australia.Advances in Ovarian Cancer Research: Exploiting Vulnerabilities, October 17 - 20, 2015, Florida, USA. Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, March 6—10, 2016, Canada, General Assembly and International Conference of Asian Pacific Organisation for Cancer Prevention (APOCP), 13 - 16 April 2016, Brisbane, Australia. 6th International Symposium on Hereditary Breast and Ovarian Cancer, 10–13 May 2016, Montréal, Canada., 16th Biennial Meeting of the International Gynecologic Cancer Society, October 29 – 31, Lisbon.3rd World Congress on Ovulation Induction & Ovarian Stimulation Protocols, Fetal and Women's Imaging.The 22nd World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI).Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, Keystone Symposia: Cancer Immunotherapy Immunity and Immunosuppression Meet Targeted Therapies.Cancer and Autoimmunity 2016 — Emerging Target Therapies in Cancer & Autoimmunity.The International Federation of Gynecology and Obstetrics (FIGO).

Track 7: Ovarian Cancer

Ovarian cancer is most common in Gynecology Cancers in women who have been through the menopause (usually over the age of 50), although it can affect women of any age.As the symptoms of ovarian cancer can be similar to those of other conditions, it can be difficult to recognise. However, there are early symptoms to look out for, such as persistent bloating, pain in the pelvis and lower stomach, and difficulty eating. The treatment you receive for ovarian cancer will depend on several things, including the stage of your cancer and your general health. Chemotherapy is the main treatment for ovarian cancer, but your treatment will usually involve a combination of surgery and chemotherapy.

Related Gynecologic conferences | Gynecology conferences | Oncology conferences  

 Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA.International Conference on Cervical Cancer, September 22-23, 2016 Vienna, Austria. International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil. 7th Global Summit on Cancer Therapy, October 05-07, 2015, Dubai,UAE. Cancer Diagnostics Conference & Expo, June 13-15,2016 Rome, Italy. 8th Euro Global Summit on Cancer Therapy , November 03-05, 2015, Valencia,Spain.. 2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. 2nd International Conference on Antimicrobial Agents and Chemotherapy, June 06-07,2016 Dallas, USA.International Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Alanta,USA. 9th Indo Global Summit on Cancer Therapy, November 02-04, 2015, Hyderabad,India.International Conference on Leukemia and Bone marrow Transplantation, November 10-12,2016,Istanbul,Turkey.ASCO/BGICS Joint Session at the Breast Gynecological International Cancer Conference, January 14- 15, 2016, Egypt.ASCO/RUSSCO Joint Session at the Russian Gynecological Cancer Conference, March 18- 19, 2016, Russia, , Tenth AACR-JCA Joint Conference on Breakthroughs in Cancer Research: From Biology to Therapeutics, February 16 - 20, 2016 Hawaii, USA. The International Federation of Gynecology and Obstetrics (FIGO), 4-9 October 2015, Vancouver, Canada.International Symposium on Advanced Ovarian Cancer: Optimal Therapy, 06 Mar 2016, Valencia, Spain.International Symposium on Advanced Ovarian Cancer: Optimal Therapy 2015, Polycystic Ovarian Syndrome Conference.Women's Health Western Caribbean Cruise - December 2015,27– 3 January 2016,Fort Lauderdale, United States.Selected Topics in Nephrology, Primary Care and Women's Health Eastern Caribbean Cruise,23–30 January 2016,Fort Lauderdale, United States.Family Medicine: Women's Health Eastern Caribbean Cruise,28 – 6 March 2016,Fort Lauderdale, United States.2nd EMEL Symposium on Endometriosis and Chronic Pelvic Pain,4–5 March 2016,Dubai, United Arab Emirates.23rd World Congress on Controversies in Obstetrics, Gynecology and Infertility,21–23 March 2016,Melbourne, Australia.

Track 8: Endometrial Cancer

Endometrial cancer is a type of cancer that begins in the uterus. The uterus is the hollow, pear-shaped pelvic organ in women where fetal development occurs. Endometrial cancer is often detected at an early stage because it frequently produces abnormal vaginal bleeding, which prompts women to see their doctors. If endometrial cancer is discovered early, removing the uterus surgically often cures endometrial cancer. Endometrial cancer can spread to other parts of your body, making it more difficult to treat successfully. Endometrial cancer that spreads (metastasizes) most often travels to the lungs.

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

International Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Alanta,USA. 4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai, UAE. 2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. 2nd International Conference on Antimicrobial Agents and Chemotherapy, June 06-07,2016 Dallas, USA. Cancer Diagnostics Conference & Expo, June 13-15,2016 Rome, Italy.International Conference on Leukemia and Bone marrow Transplantation, November 10-12,2016,Istanbul,Turkey.International Conference on Oral, Mouth and Throat, August 18-20, 2016, Portland, USA.International Conference on Mesothelioma, November 03-04, 2016, Valencia, spain. International Conference on Leukemia and Bone marrow Transplantation, November 10-12,2016,Istanbul,Turkey.International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil.12th Focus on Gynecologic Cancers Conference, October 9, 2015, Philadelphia, PA. SGO Annual Meeting on Women’s Cancer, March 19-22, 2016, San Diego, CA.NCRI Cancer Conference,01-04 November,2015,UK. IARC 50th Anniversary Conference, 7–10 June 2016, Lyon, France, NRG Oncology january 2016 Meeting resources, January 21-24, 2016 in Atlanta, GA.19th SIS World Congress on Breast Healthcare,5–8 May 2016,Warsaw, Poland.INSUOG 2016,6–8 May 2016,HYDERABAD, India.6th International Symposium on Hereditary Breast and Ovarian Cancer,10–13 May 2016,Montréal, Canada.Primary Care and Women's Health: Key Topics and Core Strategies Eastern Caribbean Cruise,5–12 June 2016,Fort Lauderdale, United States.Women's Health Western Mediterranean Cruise,31 July – 7 August 2016,Barcelona, Spain.

Track 9: Cervical Cancer

Cervical cancer is a type of cancer that develops in a woman's cervix (the entrance to the womb from the vagina).Cancer of the cervix often has no symptoms in its early stages. If you do have symptoms, the most common is unusual vaginal bleeding, which can occur after sex, in between periods or after the menopause. Almost all cases of cervical cancer are caused by the human papilloma virus (HPV). HPV is a very common virus that can be passed on through any type of sexual contact with a man or a woman. Treatment may include surgery, radiation therapy, chemotherapy, or a combination. The choice of treatment depends on the size of the tumor.

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

10th Global Annual Oncologists Meeting,July 11-13, 2016 Cologne, Germany.International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil. International Conference on Cervical Cancer,September22to23,2016Vienna,Austria.Global Summit on Melanoma and Carcinoma,July 14-15, 2016, Brisbane, Australia.International Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Alanta,USA.4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai,7th Global Summit on Cancer Therapy, October 05-07, 2015, Dubai,UAE.Markers in Cancer Diagnostic Development Tutorial,  December 1-2, 2015 Brussels, Belgium. Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, March 6—10, 2016, Canada. 2nd Annual Oncology Asia, Sep 14- 17 2015, Tokyo, Japan.Cancer-2016 International Cancer Study & Therapy Conference, April 4-6, 2016   Baltimore,USA. 8th General Assembly and International Conference of Asian Pacific Organization for Cancer Prevention (APOCP8),April 13-16,2016,Australia.Pregnancy and Childbirth 2016,13–15 September 2016,London, United Kingdom.16th Biennial Meeting of the International Gynecologic Cancer Society,29–31 October 2016,Lisbon, Portugal.Cancer Vaccines: Targeting Cancer Genes for Immunotherapy,6–10 March 2016,Whistler, Canada.Changing Prospects for Cancer 'A good survival',11 March 2016,Manchester, United Kingdom.General Assembly and International Conference of Asian Pacific Organisation for Cancer Prevention (APOCP),13–16 April 2016,Brisbane, Australia.

Track 10: Uterine Cancer

Uterine cancer is the most common cancer of a woman’s reproductive system. Uterine cancer begins when normal cells in the uterus change and grow uncontrollably, forming a mass called a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can spread to other parts of the body. There are two major types of uterine cancer 1)Adenocarcinoma. This makes up more than 80% of uterine cancers. It develops from cells in the lining of the uterus called the endometrium. 2)Sarcoma type of uterine cancer develops in the supporting tissues of the uterine glands or in the myometrium, which is the uterine muscle.

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA. International Conference on Mesothelioma, November 03-04, 2016, Valencia, spain. International Conference on Leukemia andBonemarrowTransplantation,November1012,2016,Istanbul,Turkey.5th World Congress on Cancer Therapy, September 28-30, 2015, Alanta,USA.4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai, UAE. 2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. 2nd International Conference on Antimicrobial Agents and Chemotherapy, June 06-07,2016 Dallas, USA. Cancer Diagnostics Conference & Expo, June 13-15,2016 Rome,Italy. 11th Asia-Pacific Oncologists Annual Meeting, July 11-13, 2016 Kuala Lumpur, Malaysia.European Cancer Congress,Sep 25-29,2016,Austria.ESMO Symposium on Signalling Pathways in Cancer 2016, Mar 04-05,2016, Spain.IMPAKT 2016 Breast Cancer Conference, May 12-14,2016, Brussels, Belgium, 11th Meet the Professor. Advanced International Breast Cancer Course (AIBCC).25th Annual Congress of the Romanian Society for Radiotherapy and Medical Oncology (RSRMO), 15-17 October, 2015, Sibiu,Romania. Innovation and Biomarkers in Cancer Drug Development (IBCD), December 3-4,2015, Brussels, Belgium.Global Cancer: Occurrence, Causes, and Avenues To Prevention,7–10 June 2016,Lyon, France44th American Association for Gynecological Laparoscopy (AAGL) Global Congress on Minimally Invasive Gynecology,15-19 November 2015, Las Vegas, Nevada, USA.Early Pregnancy and Acute Gynaecology,27-28 November 2015,  London, UK2016 Progress and Controversies in Gynecologic Oncology ,22-23 January 2016, Barcelona, Spain19th Senologic International Society (SIS) World Congress on Breast Healthcare,5-8 May 2016, Warsaw, Poland.10th Athens Congress on Women's Health and Disease (website active soon),1-3 September 2016, Athens, Greece.

Track 11: Vulvar/Vaginal cancer

Vulvar cancer is a rare type of  Oncology Gynecology cancer. It forms in a woman's external genitals, called the vulva. The cancer usually grows slowly over several years. First, precancerous cells grow on vulvar skin. This is called vulvar intraepithelial neoplasia (VIN), or dysplasia. Not all VIN cases turn into cancer, but it is best to treat it early. Radiation therapy may be used in more advanced vulvar cancer cases when disease has spread to the lymph nodes and/or pelvis. It may be performed before or after surgery. Women with vulvar cancer should have routine follow-up and exams with their oncologist, often every 3 months for the first 2–3 years after treatment. They should not have routine surveillance imaging to monitor the cancer unless new symptoms appear or tumor markers begin rising. Imaging without these indications is discouraged because it is unlikely to detect a recurrence or improve survival and is associated with its own side effects and financial costs.

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA.4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai, UAE. 2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. 2nd International Conference on Antimicrobial Agents and Chemotherapy, June 06-07,2016 Dallas, USA. Cancer Diagnostics Conference & Expo, June 13-15,2016 Rome,Italy. 11th Asia-Pacific Oncologists Annual Meeting, July 11-13, 2016 Kuala Lumpur, Malaysia.International Conference on Cervical Cancer, September 22-23, 2016 Vienna, Austria. International Conference and Expo on Molecular & Cancer Biomarkers, November 28-30, 2016 Baltimore, USA.International Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Alanta,USA. 9th Indo Global Summit on Cancer Therapy, November 02-04, 2015, Hyderabad,India.16th Biennial Meeting of the International Gynecologic Cancer Society, October 29 – 31​ in Lisbon.2nd Regional Symposium:Prevention of cervical cancer: a never-ending challenge, October 4-7, 2015,Cluj-Napoca, Romania. Markers in Cancer Diagnostic Development Tutorial. 2nd EORTC Cancer Survivorship Summit, March 31-4, 2016, Brussels, Belgium. ASCO/RUSSCO Joint Session at the Russian Gynecological Cancer Conference, March 18- 19, 2016, Russia.19th SIS World Congress on Breast Healthcare,5–8 May 2016,Warsaw, Poland.INSUOG 2016,6–8 May 2016,HYDERABAD, India.6th International Symposium on Hereditary Breast and Ovarian Cancer,10–13 May 2016,Montréal, Canada.Primary Care and Women's Health: Key Topics and Core Strategies Eastern Caribbean Cruise,5–12 June 2016,Fort Lauderdale, United States.Women's Health Western Mediterranean Cruise,31 July – 7 August 2016,Barcelona, Spain.Pregnancy and Childbirth 2016,13–15 September 2016,London, United Kingdom.

Track 12: Cancer Drugs

The implementation of new drug treatments has improved the prognosis for advanced cancers of the cervix, uterus, and ovary. Platinum analogs are the most effective drugs in the treatment of ovarian cancer. Fertility drugs (FD) are spreading worldwide fast and therefore many studies have reviewed the possible association between the use of these drugs and cancer. Since the drugs used for ovulation induction during in vitro fertilization (IVF) like hCG, hMG, rFSH increase the levels of gonadal hormones, concerns have grown regarding the risk of developing cancer in breast, ovary, endometrium, and other target organs.If the treatment plan involves chemotherapy you may experience physical, emotional, and/or psychological side effects related to this treatment. The side effects of ovarian cancer treatment depend on the type of treatment and may be different for each woman

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA.7thInternationalConferenceonBiomarkers&ClinicalResearch,November28to30,2016Baltimore. 10th Global Annual Oncologists Meeting,July 11-13, 2016 Cologne, Germany. 2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. 2nd International Conference on Antimicrobial Agents and Chemotherapy, June 06-07,2016 Dallas, USA.International Conference on Oral, Mouth and Throat, August 18-20, 2016, Portland, USA. International Conference on Mesothelioma, November 03-04, 2016, Valencia, spain.5th World Congress on Cancer Therapy, September 28-30, 2015, Alanta,USA.International Conference on Cervical Cancer, September 22-23, 2016 Vienna, Austria.International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil.2016 Progress and Controversies in Gynecologic Oncology Conference, January 22-23 2016, Spain. 19th International Meeting of the European Society of Gynaecological Oncology, October 24-27 2015, Nice, France. 5th MD Anderson International Meeting in Gynecologic Oncology February 24th to 26th, 2016,USA. Markers in Cancer Diagnostic Development Tutorial, VI InterAmerican Oncology Conference, October 8th-9th, 2015, Argentina.3rd World Congress on Ovulation Induction & Ovarian Stimulation Protocols, Fetal and Women's Imaging,The 22nd World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI)Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, Keystone Symposia: Cancer Immunotherapy Immunity and Immunosuppression Meet Targeted Therapies.Cancer and Autoimmunity 2016 — Emerging Target Therapies in Cancer & Autoimmunity.The International Federation of Gynecology and Obstetrics (FIGO).International Symposium on Advanced Ovarian Cancer: Optimal Therapy 2015, Polycystic Ovarian Syndrome Conference.Women's Health Western Caribbean Cruise - December 2015,27– 3 January 2016,Fort Lauderdale, United States.

Track 13: Gynecologic Oncology: Pathogenesis

Gestational trophoblastic disease (GTD) is the general name for a group of rare tumors that occur during pregnancy in the fetalchorion, GTD can occur in any kind of pregnancy which is almost always curable if found early in Oncology Gynecology Pathogenesis. Uterine leiomyosarcoma (LMS) is a rare uterine malignancy it is an aggressive tumor associated with a high risk of recurrence and death, regardless of stage.Choriocarcinoma is a cancer that develops most commonly from abnormal placenta and it is nearly 100% curable if appropriate chemotherapy is administered after the tumor mass is separated from inside the uterus.

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA.11th Asia-Pacific Oncologists Annual Meeting, July 11-13, 2016 Kuala Lumpur, Malaysia. International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil. International Conference on Cervical Cancer, September 22-23, 2016 Vienna, Austria. 10th Global Annual Oncologists Meeting,July11to13,2016Cologne,Germany.International Conference on Oral, Mouth and Throat, August 18-20, 2016, Portland, USA. International Conference on Mesothelioma, November 03-04, 2016, Valencia, spain. IInternational Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Alanta,USA.4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai, UAE.3rd Gynecology and Obstetrics Conference,8th-9th October Abu Dhabi, UAE. ESMO Symposium on Immuno-Oncology, Nov 20 - 21 2015, Switzerland. IARC 50th Anniversary Conference, 7–10 June 2016, Lyon, France.2nd EORTC Cancer Survivorship Summit, March 31-4, 2016, Brussels, Belgium.6th International Symposium on Hereditary Breast and Ovarian Cancer, 10–13 May 2016, Montréal, Canada.Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, Keystone Symposia: Cancer Immunotherapy Immunity and Immunosuppression Meet Targeted Therapies.Cancer and Autoimmunity 2016 — Emerging Target Therapies in Cancer & Autoimmunity.The International Federation of Gynecology and Obstetrics (FIGO) ,International Symposium on Advanced Ovarian Cancer: Optimal Therapy 2015, Polycystic Ovarian Syndrome Conference.Women's Health Western Caribbean Cruise - December 2015,27– 3 January 2016,Fort Lauderdale, United States.Selected Topics in Nephrology, Primary Care and Women's Health Eastern Caribbean Cruise,23–30 January 2016,Fort Lauderdale, United States.

Track 14: Gynecologic Surgery 

In Oncology Gynecology the Gynecologic Surgical methods include- Initial Debulking surgery,   which may be performed by variety of procedures depending on the type & stage of ovarian cancer based on individual fertility concerns. The procedure for removal of ovary and fallopian tubes is known as Bilateral salpingo-oophorectomy surgery. The surgical removal of uterus and cervix is known as.Total hysterectomy. Lymph node biopsy will be performed by collecting the fluid sample from the abdomen. Omentectomy is surgical process for removing of omentum partially or as a whole. Fold of fatty tissue inside the abdomen is known as Omentum.  

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA.International Conference on Leukemia and Bone marrow Transplantation, November 10-12,2016,Istanbul,Turkey.7thInternationalConferenceonBiomarkers&ClinicalResearch,November28to30,2016Baltimore. 10th Global Annual Oncologists Meeting,July 11-13, 2016 Cologne, Germany. 2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. 2nd International Conference on Antimicrobial Agents and Chemotherapy, June 06-07,2016 Dallas, USA.International Conference on Oral, Mouth and Throat, August 18-20, 2016, Portland, USA. 5th World Congress on Cancer Therapy, September 28-30, 2015, Alanta,USA.International Conference on Cervical Cancer, September 22-23, 2016 Vienna, Austria.International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil.2016 Progress and Controversies in Gynecologic Oncology Conference, January 22-23 2016, Spain. 19th International Meeting of the European Society of Gynaecological Oncology, October 24-27 2015, Nice, France. 5th MD Anderson International Meeting in Gynecologic Oncology February 24th to 26th, 2016,USA. Markers in Cancer Diagnostic Development Tutorial, VI InterAmerican Oncology Conference, October 8th-9th, 2015, Argentina.3rd World Congress on Ovulation Induction & Ovarian Stimulation Protocols, Fetal and Women's Imaging,The 22nd World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI)Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, Keystone Symposia: Cancer Immunotherapy Immunity and Immunosuppression Meet Targeted Therapies.Cancer and Autoimmunity 2016 — Emerging Target Therapies in Cancer & Autoimmunity.The International Federation of Gynecology and Obstetrics (FIGO).International Symposium on Advanced Ovarian Cancer: Optimal Therapy 2015, Polycystic Ovarian Syndrome Conference.Women's Health Western Caribbean Cruise - December 2015,27– 3 January 2016,Fort Lauderdale, United States.

Track 15: Sexual and Reproductive issues

The problems with sexuality and fertility persist for women treated for cervical cancer despite these advances. Sexual dysfunction following treatment for gynecology cancer has been well documented in the literature, and recent studies demonstrate the success of brief psychosexual interventions in gynecology cancers . Treatment of sexual difficulties in cancer patients can be achieved through the provision of information, support, and symptom management, ideally as part of a sexual health program. Resources are not always available to develop such a program. However, medical professionals like gynecologic oncologist’s  can identify individuals and organizations with expertise in treating sexual and fertility concerns, which can be provided to their patients, making help with these problems more accessible as needs arise.

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA.4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai, UAE. 2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. Cancer Diagnostics Conference & Expo, June 13-15,2016 Rome,Italy. 11th Asia-Pacific Oncologists Annual Meeting, July 11-13, 2016 Kuala Lumpur, Malaysia.International Conference on Cervical Cancer, September 22-23, 2016 Vienna, Austria. International Conference and Expo on Molecular & Cancer Biomarkers, November 28-30, 2016 Baltimore, USA. Global Summit on Melanoma and Carcinoma,July 14-15, 2016, Brisbane, Australia.International Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Alanta,USA. 9th Indo Global Summit on Cancer Therapy, November 02-04, 2015, Hyderabad,India.16th Biennial Meeting of the International Gynecologic Cancer Society, October 29 – 31​ in Lisbon.2nd Regional Symposium:Prevention of cervical cancer: a never-ending challenge, October 4-7, 2015,Cluj-Napoca, Romania. Markers in Cancer Diagnostic Development Tutorial. 2nd EORTC Cancer Survivorship Summit, March 31-4, 2016, Brussels, Belgium. ASCO/RUSSCO Joint Session at the Russian Gynecological Cancer Conference, March 18- 19, 2016, Russia.19th SIS World Congress on Breast Healthcare,5–8 May 2016,Warsaw, Poland.INSUOG 2016,6–8 May 2016,HYDERABAD, India.6th International Symposium on Hereditary Breast and Ovarian Cancer,10–13 May 2016,Montréal, Canada.Primary Care and Women's Health: Key Topics and Core Strategies Eastern Caribbean Cruise,5–12 June 2016,Fort Lauderdale, United States.Women's Health Western Mediterranean Cruise,31 July – 7 August 2016,Barcelona, Spain.Pregnancy and Childbirth 2016,13–15 September 2016,London, United Kingdom.

Track 16: Role of imaging in Gynecologic Oncology

Oncology Gynecology the endometrial cancer, MRI is used to identify myometrial invasion and extrauterine disease, allowing preoperative surgical planning in women with serious comorbidity. In cervical cancer, MRI has an established role in local staging. By assessing the proximal extension of tumours in young women, MRI determines the feasibility of fertility-preserving surgery. It is also used to plan and administer radiotherapy. This optimises tumour radiation, while limiting unwanted radiation to the bowel and other pelvic organs.Gynecology Cancer the ovarian cancer, MRI is useful in young women as it is superior to ultrasound in diagnosing endometriomas, dermoids and fibroids, which can be misdiagnosed by ultrasound as malignant lesions.

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA.10th Global Annual Oncologists Meeting,July 11-13, 2016 Cologne, Germany. International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil. International Conference on Cervical Cancer, September 22-23, 2016 Vienna, Austria. Global Summit on Melanoma and Carcinoma,July 14-15, 2016, Brisbane, Australia.4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai, UAE. 2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. 2nd International Conference on Antimicrobial Agents and Chemotherapy, June 06-07,2016 Dallas, USA. Cancer Diagnostics Conference & Expo, June 13-15,2016 Rome,Italy. 11th Asia-Pacific Oncologists Annual Meeting, July 11-13, 2016 Kuala Lumpur, Malaysia.International Conference and Expo on Molecular & Cancer Biomarkers, November 28-30, 2016 Baltimore,USAAdvanced Course in Cytoreductive Surgery for Gynecology Peritoneal Surface Malignancies, Oct. 9-10, 2015,California.International Society for the Study of Women's Sexual Health (ISSWSH) Fall Course 2015, October 9-11,2015,USA.Women's OB/GYN Imaging Update, November 11-13, 2015, Palm Springs, CA. ESMO Symposium on Signalling Pathways in Cancer 2016, Mar 04-05,2016, Spain. General Assembly and International Conference of Asian Pacific Organisation for Cancer Prevention (APOCP), 13 - 16 April 2016, Brisbane, Australia.Global Cancer: Occurrence, Causes, and Avenues To Prevention,7–10 June 2016,Lyon, France.44th American Association for Gynecological Laparoscopy (AAGL) Global Congress on Minimally Invasive Gynecology,15-19 November 2015, Las Vegas, Nevada, USA.Early Pregnancy and Acute Gynaecology,27-28 November 2015,  London, UK.2016 Progress and Controversies in Gynecologic Oncology ,22-23 January 2016, Barcelona, Spain.19th Senologic International Society (SIS) World Congress on Breast Healthcare,5-8 May 2016, Warsaw, Poland.10th Athens Congress on Women's Health and Disease (website active soon),1-3 September 2016, Athens, Greece.

Track 17: Clinical Gynecologic Oncology

The vast majority of the lesions that occur in the breast are benign. Much concern is given to malignant lesions of the breast because breast cancer is the most common malignancy in women in Western countries; however, benign lesions of the breast are far more frequent than malignant ones of Clinical Gynecologic Cancer.With the use of mammography, ultrasound, and magnetic resonance imaging of the breast and the extensive use of needle biopsies.Most importantly, a pregnant woman with cancer is capable of giving birth to a healthy baby because cancer rarely affects the fetus directly. Although some cancers may spread to the placenta, most cancers cannot spread to the baby. However, being pregnant with cancer is extremely complicated for both the mother and the health care team. Transfusion of one or more of the components of whole blood. The blood components may have been taken from the patient previously (autologous transfusion) or donated by someone else (homologous transfusion). Except in the case of acute hemorrhage, the transfusion of whole blood is rarely needed

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. 7th Global Summit on Cancer Therapy, October 05-07, 2015, Dubai,UAE. Global Summit on Melanoma and Carcinoma,July 14-15, 2016, Brisbane, Australia. International Conference on Pancreatic and Colorectal Cancer, March 29-30, 2016, Alanta,USA. 9th Indo Global Summit on Cancer Therapy, November 02-04, 2015, Hyderabad,India.4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai, UAE.11th Asia-Pacific Oncologists Annual Meeting, July 11-13, 2016 Kuala Lumpur, Malaysia.International Conference on Leukemia and Bone marrow Transplantation, November 10-12,2016,Istanbul,Turkey.International Conference on Oral, Mouth and Throat, August 18-20, 2016, Portland, USA. International Conference on Mesothelioma, November 03-04, 2016, Valencia, spain.Cervical cancer Prevention: 20 years of progress & A path to the Future, February 17-18, 2010,Monte Carlo,Monacco. IARC 50th Cancer Conference Anniversary, 7–10 June 2016, Lyon, France. 6th International Symposium on Hereditary Breast and Ovarian Cancer, 10–13 May 2016, Montréal, Canada, Next NRG Oncology Semiannual Meeting, January 21 - 24, 2016, Atlanta,GA. Cancer and Autoimmunity 2016 — Emerging Target Therapies in Cancer & Autoimmunity.International Symposium on Advanced Ovarian Cancer: Optimal Therapy 2015, Polycystic Ovarian Syndrome Conference.Women's Health Western Caribbean Cruise - December 2015,27– 3 January 2016,Fort Lauderdale, United States.Selected Topics in Nephrology, Primary Care and Women's Health Eastern Caribbean Cruise,23–30 January 2016,Fort Lauderdale, United States.Family Medicine: Women's Health Eastern Caribbean Cruise,28 – 6 March 2016,Fort Lauderdale, United States.2nd EMEL Symposium on Endometriosis and Chronic Pelvic Pain,4–5 March 2016,Dubai, United Arab Emirates.

Track 18: Gynecologic Oncology: Prevention

The suitable Screening and self-examinations conducted regularly can result in the detection of certain types of Oncology Gynecology for successful treatment in their early stages. Proper Nutrient diet, physical exercise and standard of living choices play a significant role in the prevention of cancer. Over and above, awareness of family history can increase the chance of prevention or early diagnosis for to detect any gene susceptible to cancer.

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA.4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai, UAE. 2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. 2nd International Conference on Antimicrobial Agents and Chemotherapy, June 06-07,2016 Dallas, USA.11th Asia-Pacific Oncologists Annual Meeting, July 11-13, 2016 Kuala Lumpur, Malaysia.International Conference on Cervical Cancer, September 22-23, 2016 Vienna, Austria. International Conference and Expo on Molecular & Cancer Biomarkers, November 28-30, 2016 Baltimore, USA. Global Summit on Melanoma and Carcinoma,July 14-15, 2016, Brisbane, Australia.10th Global Annual Oncologists Meeting,July 11-13, 2016 Cologne, Germany. International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil.Mayo Clinic Gynecology and Gynecologic Surgery Update, October 1 - 3,2015, Orlando, FL.Advanced Gynecologic Surgery: A Dual Track, Hands-On Cadaver Lab, October 9-10, 2015, United States. 2nd Annual Oncology Asia, Sep 14- 17 2015, Tokyo, Japan. ESMO Symposium on Immuno-Oncology, Nov 20 - 21 2015, Switzerland. Cancer-2016 International Cancer Study & Therapy Conference, April 4-6, 2016   Baltimore,USA.44th American Association for Gynecological Laparoscopy (AAGL) Global Congress on Minimally Invasive Gynecology,15-19 November 2015, Las Vegas, Nevada, USA.Early Pregnancy and Acute Gynaecology,27-28 November 2015,  London, UK.2016 Progress and Controversies in Gynecologic Oncology ,22-23 January 2016, Barcelona, Spain.19th Senologic International Society (SIS) World Congress on Breast Healthcare,5-8 May 2016, Warsaw, Poland.10th Athens Congress on Women's Health and Disease (website active soon),1-3 September 2016, Athens, Greece.

Track 19Cancer and Primary care

As the world becomes more complex and knowledge in every field becomes more extensive and detailed, it’s increasingly difficult to master everything in any one area. This is certainly true in the field of Gynecologists practice, which is undoubtedly one of the reasons for the recent trend towards specialization. However, this is only one of many factors contributing to the shift. Today, the multitude of pressures affecting Radiologists in general—and comprehensive Gynecologists in particular has become so oppressive that many doctors wonder whether comprehensive Gynecologists can survive.

Related Gynecologic conferences | Gynecology conferences | Oncology conferences 

Experts Meeting on Gynecologic Oncology, May 19-21, 2016 San Antonio, Texas, USA.11th Asia-Pacific Oncologists Annual Meeting, July 11-13, 2016 Kuala Lumpur, Malaysia. International Conference and Exhibition on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil. International Conference on Cervical Cancer, September 22-23, 2016 Vienna, Austria. .4th International Conference on Blood Malignancies and Treatment, April 18-20, 2016, Dubai, UAE. 2nd International Conference on Prostate Cancer and Treatment, May 05-07, 2016,Chicago, USA. 2nd International Conference on Antimicrobial Agents and Chemotherapy, June 06-07,2016 Dallas, USA. Cancer Diagnostics Conference & Expo, June 13-15,2016 Rome,Italy.Global Summit on Melanoma and Carcinoma,July 14-15, 2016, Brisbane, Australia.3rd Gynecology and Obstetrics Conference,8th-9th October Abu Dhabi, UAE. ESMO Symposium on Immuno-Oncology, Nov 20 - 21 2015, Switzerland. IARC 50th Anniversary Conference, 7–10 June 2016, Lyon, France.2nd EORTC Cancer Survivorship Summit, March 31-4, 2016, Brussels, Belgium.6th International Symposium on Hereditary Breast and Ovarian Cancer, 10–13 May 2016, Montréal, Canada.Primary Care and Women's Health: Key Topics and Core Strategies Eastern Caribbean Cruise,5–12 June 2016,Fort Lauderdale, United States.Women's Health Western Mediterranean Cruise,31 July – 7 August 2016,Barcelona, Spain.Pregnancy and Childbirth 2016,13–15 September 2016,London, United Kingdom.16th Biennial Meeting of the International Gynecologic Cancer Society,29–31 October 2016,Lisbon, Portugal.Cancer Vaccines: Targeting Cancer Genes for Immunotherapy,6–10 March 2016,Whistler, Canada.Changing Prospects for Cancer 'A good survival',11 March 2016,Manchester, United Kingdom.

 

 

Theme: Integrating the Milestones in Gynecologic Oncology Globally

 

Summary

Gynecology oncology is the field of medicine that focuses on cancers of the female generative system, including vaginal cancer, ovarian cancer, cervical cancer,uterine cancer. As experts they have wide training in the diagnosis and treatment of these cancers.

In 2012, there were about 4.7 million cases of women cancer worldwide in which 54% casesarose in less developed countries. Gynecologic Cancers, with cancer of the vulva, vagina, endometrium, ovary, placenta and adnexa, accounted for 9% of all female major tumours worldwide and 45% of all genital cancers.

Although the occurrence and mortality from endometrial and ovarian cancer are major, other cancers are very uncommon. Primary cancers of the vulva, vagina, placenta and adnexa total 0.6% of all woman cancers.

Gynecologic Cancer Statistics

In the world 82,000 women are identified with Gynecologic cancer each year. In 2013, an expected 91,730 were diagnosed.

An estimated 88,000 new cases of Gynecologic cancer were expected to be diagnosed in 2014 in the U.S.A, and over 29,000 American females will lose their battle with this deadly disease. In addition to imposing a significant load on patients and their relations, Gynecologic cancer places a major burden on the health care organization. Despite advances in cancer care in the United States, cancer-related diseases and death for advanced and recurrent Gynecologic malignancies remain at intolerable stages.  Endometrial cancer has seen a slight rise in both new cancer incidents and annual death rates over the past 30 years.

Every woman is at risk for emerging a Gynecologic Cancer. It is expected that there will be about 98,000 new cases diagnosed and around 30,000 deaths from Gynecologic Cancers in the United States during 2015.

 

 

Cancer of the Ovary

Accounting for 3% of all cancers in women and figuring more than 165,000 new cases estimated in2013, ovarian cancer is the sixth most common female cancer and the sixth prominent cause of death in women globally. In Canada, ovarian cancer accounts for 4% of all female cancers or 31%ofall genital cancers in women, it is estimated that in 2014 there were 2,500 new cases and 1,500 deaths

There is large variation in incidence rates of ovarian cancer worldwide, from 3/100,000 in central Africa to 13/100,000 in northern Europe. Developing nations have incidence rates that are nearly half those of the most resource-rich countries. Canada and the United States are the countries with the highest rates of ovarian cancer globally, with rates of 12 and 11 per 100,000 respectively. Within countries, mortality rates are generally negative indicators of the region's incidence, and unlike the situation for other Gynecologic Cancers, mortality from ovarian cancer does not seem to be related to the country's level of development.

Cancer of the Vulva

Although tumours in the vulva occur two to three times as frequently as those in the vagina, they are still a rare finding. The cancer registry reporting the most elevated incidence rate of vulvar cancer is that of Prince Edward Island in Canada (2.6/100,000 women). Rates above 2/100,000 are found elsewhere, in Peru and Brazil (2.5/100,000 and 2.3/100,000 respectively). All provinces in Canada have rates above 1/100,000 women; these are among the highest reported internationally.

Cancer of the Endometrium

Most neoplasias of the corpus of the uterus develop in the endometrium which is the seventh most common malignancy affecting women worldwide, with almost 190,000 cases annually It is the most common uterine malignancy in Canada, accounting for 43% of all female genital cancers.

There is great difference in the incidence rates of endometrium internationally. The highest threat areas are Central and North America and Polynesia, whereas rates that are 10 times lower occur in western Africa. Canada and the United States Incidence rates are among the 20 highest worldwide (14.9 and 15.5 per 100,000 respectively). High-risk countries with better resources tend to have relatively low mortality rates.

Cancer of the Vagina

Neoplasms of the vagina are extremely uncommon. The reported annual age-standardized incidence rate is less than 1/100,000 women in all countries with the exception of Argentina (1.5/100,000) and Colombia (1.2/100,000). Nova Scotia is the Canadian province with the highest ASIR for vaginal cancers at 0.8/100,000 which is ranked fourth highest in the world. For the other reporting provinces, rates vary between 0.3/100,000 and 0.7/100,000. Since neoplasia found in the vagina may represent infiltration of primary cancers occurring in a different place in the body, it is possible that such rates are inflated.

Incidence Rate in USA:

 

Scope and Importance of Gynecologic Oncology Research

Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

Cervical cancer is the third most commonly diagnosed cancer and the fourth leading cause of cancer death in females’ worldwide, accounting for 9% (529,800) of the total new cancer cases and 8% (275,100) of the total cancer deaths among females. More than 85% of these cases and deaths occur in developing countries.

Tumor biology early detection, and treatment of ovarian cancer in older women as compared to younger women suffering with this malignancy. Effort was devoted to the type of problems met in conducting the analyses and, where data were inadequate, recommending research guidelines or approaches.

The center are at the forefront of research in the early discovery of ovarian cancer and uterine cancer , which is involved in developing blood tests to precisely determine the absence or presence of early stage ovarian cancer before it reveals, as well as on going translational research programs for all Gynecologic Cancers.  Physicians are also involved in leading-edge programs in the prevention of cervical cancer through regular screenings and the identification of precancerous cervical lesions associated with papilloma virus infections.

Organized screening procedures can support to detect Gynecologic Cancer, including cervical cancer, uterine cancer, and ovarian cancer, early.

A pap smear can identify cervical and uterine cancers. It is suggested to begin analysis every three years early at age 21.

A pelvic exam images the rectum, vagina, cervix, fallopian tubes, uterus, ovaries, and Pelvic tests should be done annually, beginning at 21 and can help detect irregularities of the female reproductive system.

An endometrial tissue sample checks for abnormal cells or signs of uterine cancer which can be done for women with a high risk for endometrial cancer due to an inborn susceptibility or when there are symptoms that need to be evaluated.

 

Why it’s in San Antonio, USA.

Gynecologic Cancer confers a large burden among women in the United States. Several evidence-based interventions are available to reduce the incidence, morbidity, and mortality from these cancers. The National Comprehensive Cancer Control Program (NCCCP) is uniquely positioned to implement these interventions in the US population. Every woman is at risk for developing a Gynecologic Cancer. It is estimated that there will be about 91,000 new cases diagnosed and approximately 28,000 deaths from Gynecologic Cancers in the United States during 2014.Post-menopausal women aged 45–70 years have the highest risk of developing uterine cancer. It is more common in Caucasian women than in other populations. Women living in North America or Europe develop uterine cancer more often than those living in other parts of the world. Women in higher income groups also tend to be affected more often than women in lower income groups.

Members Associated with Gynecologic Oncology Research

Gynecologic Oncology research associated members in San Antonio are about 418,in USA 5684 members and worldwide about 10214 research members.

 

 

Hospitals Associated with Gynecologic Oncology Research

 

Major Gynecologic Oncology associated hospitals in San Antonio are around 2% when compared to worldwide.

 Hospitals in San Antonio and USA are:

  • San Antonio Cancer Care

  • Methodist Hospital

  • Southwest General Hospital

  • Cancer Care Centers of South Texas

  • Methodist Women's Center

  • Metropolitan Methodist Hospital

  • South Texas Oncology Group

  • Advocate Good Samaritan Hospital

  • Anderson Hospital

  • Aspirus Wausau Hospital

  • Aultman Hospital

  • Aurora St. Luke's Medical Center

  • Banner Good Samaritan Medical Center

  • Barnes-Jewish Hospital

  • Beaumont Hospital

  • Bon Secours Memorial Regional Medical Center

  • Boone Hospital Center

  • Boston Medical Center

  • Brigham and Women's Hospital

  • Bryn Mawr (Pa.) Hospital

  • Carle Foundation Hospital

  • Cedars-Sinai Medical Center

  • Christiana Hospital

  • Dartmouth-Hitchcock Medical Center

  • Duke University Hospital

  • Emory University Hospital

  • Evanston (Ill.) Hospital

  • Fairview Southdale Hospital

  • Flagler Hospital

  • Florida Hospital

  • Glendale (Calif.) Memorial Hospital and Health Center

  • Gundersen Lutheran Medical Center

  • Hackensack (N.J.) University Medical Center

  • Halifax Health Medical Center of Daytona Beach

  • Hutzel Women's Hospital

  • Hartford (Conn.) Hospital

  • Holy Cross Hospital

  • Hospital of the University of Pennsylvania

  • Huntington Hospital

  • Indiana University Health Methodist Hospital/University Hospital (Indianapolis)

  • Ingalls Memorial Hospital

  • Inova Fairfax Hospital

  • Johns Hopkins Hospital

  • Keck Hospital of the University of Southern California

  • Lancaster (Pa.) General Hospital

  • LDS Hospital

  • Magee-Womens Hospital of UPMC

  • Massachusetts General Hospital

  • MedStar Georgetown University Hospital

  • Memorial Hermann Memorial City Medical Center

 

  

Societies Associated with Gynecologic Oncology Research

 

In world there are about 9,685 societies which are specifically associated with Gynecologic Oncology, in which 1289 societies are from USA and the remaining 269 societies are from San Antonio.

American gynecological and obstetrics society

American society of clinical oncology

National cancer institute

Society of Gynecologic Oncology

Society of Gynecologic nurse Oncologists

International Gynecologic cancer society

American college of Phlebology

American congress of Obstetricians and Gynecologists

Asian Society of Gynecologic Oncology

Female Genital Tract Pathology

Foundation for Women's Cancer

GYN-ONC - Gynecologic Cancers Support Group

Gynecologic Oncology

Gynecologic Oncology Group

Northern Gynecologic Oncology Centre

Queensland Centre for Gynecologic Oncology

 

   

Industries Associated with Gynecologic Oncology Research

Industries associated with Gynecologic cancer over all world is about 85% in which 12% of industries are in USA and in San Antonio about 3%.

 

·        Johnson & Johnson

·        Novartis

·        Roche

·        Pfizer

·        Sanofi

·        Merck

·        Bristol-myers squibb

·        Eli Lilly

·        Celgene

·        Takeda

·        AstraZeneca

·        Merck & Co.

·        Amgen

·        Bayer

·        Otsuka

·        Pharmacyclics

·        Incyte

Universities Associated with Gynecologic Oncology Research

Gynecologic cancer associated universities in world are about 3284, in USA 612 universities.

The University of Texas at San Antonio

The University of Texas Health Science centre at San Antonio

Trinity University

St. Mary's University

Our Lady of the Lake University

Baptist University of the Americas

University of Texas Medical Branch

University of Texas Medical School at Houston

University of Texas Rio Grande Valley School of Medicine

Dell Medical School at The University of Texas at Austin

University of Alabama School of Medicine

University of Arizona College of Medicine

Charles R. Drew University of Medicine and Science

Keck School of Medicine of University of Southern California

Loma Linda University School of Medicine

Stanford University School of Medicine

UC Davis School of Medicine

University of California, Irvine School of Medicine

David Geffen School of Medicine at UCLA

UC Riverside School of Medicine

University of California, San Diego School of Medicine

University of Colorado School of Medicine

Frank H. Netter M.D. School of Medicine at Quinnipiac University

University of Connecticut School of Medicine

Yale School of Medicine

George Washington University Medical School

Georgetown University School of Medicine

Howard University College of Medicine

Florida Atlantic University Charles E. Schmidt College of Medicine

Florida State University College of Medicine

University of Florida College of Medicine

University of South Florida College of Medicine

Mercer University School of Medicine

Loyola University Chicago Stritch School of Medicine

Northwestern University Feinberg School of Medicine

Rush Medical College

Indiana University School of Medicine

University of Iowa Roy J. and Lucille A. Carver College of Medicine

University of Kansas School of Medicine

University of Kentucky College of Medicine

University of Louisville School of Medicine

Louisiana State University School of Medicine in New Orleans

Tulane University School of Medicine

Johns Hopkins University School of Medicine

Boston University School of Medicine

Harvard Medical School

Oakland University William Beaumont School of Medicine

Wayne State University School of Medicine

Mayo Clinic College of Medicine

University of Minnesota Medical School

University of Mississippi School of Medicine

University of Missouri-Columbia School of Medicine

Rutgers New Jersey Medical School

University of New Mexico School of Medicine

Icahn School of Medicine at Mount Sinai

New York Medical College

New York University School of Medicine

 

Market Value on Gynecologic Oncology Research

The global Gynecologic cancer market in 2010 was valued at $54bn, an increase of 5.1% over the previous year‘s sales of $51.3bn, and is forecasted to grow at a CAGR of 6.9% from 2010–16, reaching $81bn in 2016.    Collectively, the seven major markets (US, 5EU, and Japan) represented 79.1% (or $43bn) of in the global cancer market in 2010. In terms of size, the US dominated the global cancer market, with 2010 sales of $21bn and a market share of 38.5%. The global cancer market is becoming increasingly competitive, with two therapeutic classes, namely antineoplastics and cytostatic hormonal treatments, dominating this sector. Collectively, the leading 10 brands accounted for almost 58.2% (or $31.4bn) of the global cancer market in 2010. In 2010 antineoplastics was the leading drug class in the global cancer market. The global antineoplastic market was valued at $46bn in 2010 at a year-on-year (Y-o-Y) growth of 7.3%. The major drugs that contributed to the 2010 sales in the antineoplastic category were Roche‘s Avastin (bevacizumab) at $6.2bn, Herceptin (trastuzumab) at $5.2bn, and MabThera (rituximab) at $5.1bn, with Y-o-Y sales growth of 3.8%, 3.1%, and 3.3% respectively. The cytostatic hormonal market registered 2010 sales of $8bn at a Y-o-Y decline of 6.5%. AstraZeneca‘s Arimidex (anastrozole) and Novartis‘s Femara (letrozole) led this class, reaching sales of $1.5bn and $1.3bn respectively in 2010

 

Market Growth of Gynecologic Oncology Research in the last and upcoming ten years

TechNavio's analysts forecast the Global Gynecologic Cancers market to grow at a CAGR of 12.47% over the period 2013-2018. One of the key factors contributing to this market growth is the increase in prevalence of gynecological cancer. The Global Gynecologic cancer market has also been witnessing the emergence of personalized medicines. However, the increase in use of CAM could pose a challenge to the growth of this market. In next ten years as population ages, the number of people diagnosed with cancer is expected to be double. According to the American Cancer Society, cancer accounts for every 1 of every 4 in U.S deaths, for women it is one in three .The volume of cancer services continues to grow. Radiation therapy by 3%,infusion therapy by 7% ; Gynecologic services by 10%(annually).With earlier detection,cancer patients will be identified earlier with improvements in chemotherapy,patients will be able to tolerate more treatments, all of which will result in more treatments per patient and more lives saved.

 

Fund Allotment to Gynecologic Oncology Research

Fund allotted to the individual types of Gynecologic Cancer research in Dollars for Ovarian, Cervical and Uterine cancers 147$, 119$ and 59$ in which Cervical cancer is funded majorly.

Statistics of Physicians, Researchers and Academicians working on Gynecologic Oncology

San Antonio's Biosciences industry employs over 100,000 people. The largest areas of research are conducted by institutes in or around the South Texas Medical Center. These include the oncology division of one of the world's top five biotechnology firms, the world's largest Phase I clinical trials program for new anti-cancer drugs, and the new $200 million woman’s Cancer Research Institute. San Antonio also houses the world's largest genomics computing cluster and the state's public bank for stem cell-rich umbilical cord blood.

 

Products manufactured by the industry related Gynecologic Oncology Research

Market Value:

·        Neosar (Cyclophosphamide)- manufactured by Roxane Laboratories Inc and the market value is17.06$

·        Paraplat (Carboplatin)-manufactured byBristol-Myers Squibb Companyand the market value is128$

·        Platinol (Cisplatin)-manufactured byBristol-Myers Squibb Companyand the market value is15.3$

·        Gemzar (Gemcitabine Hydrochloride)-manufactured by Eli Lilly and Companyand the market value

          is26.1$

·        Clafen (Cyclophosphamide)-manufactured bySelleckchemand the market value is150$

 

 

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date May 19-21, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2 Day 3
Poster Opportunity Closed Click Here to View

Media Partners